Lifeng Tian

5PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 08, 2022
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.

J Joseph Melenhorst, Gregory M Chen, Meng Wang

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

|Mar 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.

Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung

|Feb 03, 2022
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.

J Joseph Melenhorst, Gregory M Chen, Meng Wang

|Feb 08, 2020
CRISPR-engineered T cells in patients with refractory cancer.

Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis

Pageof 1